Comparison of HbA1c in Type 1 or Type 2 Diabetic Patients Using Insulin Treated Twice Daily With Either Insulin Lispro Low Mixture or Human Insulin Mix 30/70.
Phase of Trial: Phase IV
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Insulin neutral protamine lispro/insulin lispro (Primary) ; Insulin suspension isophane/insulin
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms IOPA
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 28 Jan 2008 Status change from in progress to completed as reported by clinicaltrials.gov.
- 08 Aug 2007 Status changed from recruiting to in progress.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History